Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
0.8600
-0.0298 (-3.35%)
Oct 29, 2026, 4:00 PM EDT - Market closed
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $53.25 million as of October 29, 2026. It is the 29,607th most valuable company in the world and the 4,572nd biggest in the United States. Its market cap has decreased by 51.27% in one year.
Market Cap
53.25M
Enterprise Value
-76.11M
1-Year Change
-51.27%
Global Rank
Country Rank
#4,572 United States
Category
ChartMarket Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $53.25M, a decrease of -92.78%. That is a compound annual growth rate of -33.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 53.25M | -28.97% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 55.50M |
| Clene | 55.43M |
| Oncolytics Biotech | 54.54M |
| Hyperion DeFi | 54.47M |
| Alps Group | 54.06M |
| Werewolf Therapeutics | 53.46M |
| Eloxx Pharmaceuticals | 53.28M |
| Connect Biopharma Holdings | 52.61M |